Embark on a faster journey to the clinic. R3 bypasses traditional fermentation to produce bright, pure, high-fidelity plasmid DNA—scaling seamlessly for your next big breakthrough.
Parallel enzymatic reaction chambers capable of synthesizing high-fidelity variants without host-cell toxicity constraints, speeding up your workflow.
Linear yield metrics allow direct, effortless transition from milligram screening preps to gram-scale clinical trial lots.
Algorithmic sequence modification engineered to resolve unstable ITRs and high-GC structural bottlenecks for smooth sailing.
Accelerate your screening phases with our rapid-turnaround plasmid preps. Synthesized with bright, proof-reading polymerases, we ensure unmatched sequence fidelity to keep your research moving forward.
100% cell-free enzymatic synthesis beautifully eliminates bacterial genomic DNA risks.
Multi-stage Sanger sequencing, restriction digest mapping, and HPLC purity profiling.
Ultra-low endotoxin thresholds (<0.005 EU/mg) strictly certified for safe in vivo trials.
Automated, pristine generation of Certificates of Analysis (CoA) and IND filing dossiers.
Pre-validated construct architectures designed to brighten up your cell and gene therapy applications.
Helper-free Rep/Cap plasmids designed for high packaging efficiency and joyful low empty-capsid ratios.
High-yield linear template vectors with standardized poly(A) tail lengths, ensuring smooth IVT mRNA synthesis.
Single and multiplex gRNA backbone architectures crafted for highly efficient knockout and knock-in editing.
Select manufacturing specs for instant, happy cost estimates.
Consult directly with our friendly vector engineering scientists.